**Core Concept**
Graves' disease is an autoimmune disorder characterized by the production of autoantibodies that stimulate the **thyroid-stimulating hormone (TSH) receptor**, leading to hyperthyroidism. This condition involves a complex interplay of immune cells and **autoantibodies**. The underlying principle being tested is the type of immunologic process involved in Graves' disease.

**Why the Correct Answer is Right**
The correct answer is related to the mechanism by which autoantibodies interact with the TSH receptor, mimicking the action of TSH and causing an increase in thyroid hormone production. This process is an example of **type II hypersensitivity reaction**, where autoantibodies bind to cell surface receptors, leading to abnormal cell activation. The autoantibodies in Graves' disease are primarily **IgG antibodies** that bind to the TSH receptor.

**Why Each Wrong Option is Incorrect**
**Option A:** This choice is incorrect because it does not accurately describe the immunologic process involved in Graves' disease.
**Option B:** This option is also incorrect as it represents a different type of hypersensitivity reaction.
**Option C:** Similarly, this choice is wrong because it does not pertain to the specific mechanism of autoantibody-mediated receptor stimulation seen in Graves' disease.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that Graves' disease is a classic example of a **type II hypersensitivity reaction**, which involves autoantibodies binding to cell surface receptors, leading to tissue damage or dysfunction. Recognizing this pattern can help in diagnosing and managing similar autoimmune conditions.

**Correct Answer:** D. Type II hypersensitivity reaction.